Irish medtech company Neuromod is to begin offering its Irish-made Lenire tinnitus treatment medical device in the United Kingdom and Switzerland, in what is a major European expansion for the company ...

Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, its tinnitus treatment device. Current investors Panakès Partners and ...

Neuromod has launched Tinnitus Masterclass, an online course that features a blend of medical and commercial tinnitus modules. Tinnitus Masterclass is aimed at audiologists and ENTs in Europe who wish ...

DUBLIN, Feb. 21, 2022 /PRNewswire/ -- Irish medical device company, Neuromod Devices Ltd. (Neuromod), has welcomed the findings of an independent study performed at the German Hearing Center (DHZ) at ...

Tom Maher joins Neuromod Devices Ltd. with more than twenty-five years of corporate legal and business experience in the international life sciences industry, including biopharma, biotech, and medtech ...

The new roles will be based initially in Ireland and Germany, where the company has an office. Dublin-based medtech Neuromod, which specialises in treating tinnitus, has closed a €10.5m Series B ...

Equity investment led by Panakès Partners with venture debt provided by European Investment Bank Financing round follows recent US FDA granting of De Novo approval to Neuromod's Lenire tinnitus ...

DUBLIN--(BUSINESS WIRE)--Neuromod Devices Limited (“Neuromod” or the “Company”), the Irish medical technology company specialising in non-invasive neuromodulation technologies, today announces the ...

With the latest funding, Neuromod aims to progress its entry into the US market while expanding operations in Europe. Today (20 October), Dublin-based medical device start-up Neuromod announced that ...

Neuromod has launched Tinnitus Masterclass, an online course that features a blend of medical and commercial tinnitus modules. Tinnitus Masterclass is aimed at audiologists and ENTs in Europe who wish ...